ASCO Daily News

134 Episodes

1. What the FDA CAR T-Cell Therapy Investigation Means for Oncologists

   Published: 7/12/2023
2. Managing the Complexities of Oncology Practice in 2024

   Published: 7/12/2023
3. Solutions and Key Research to Advance High-Quality Cancer Care

   Published: 9/11/2023
4. How to Implement Universal Germline Testing for CRC

   Published: 2/11/2023
5. Changing the Gut Microbiome to Improve the Efficacy of Immunotherapy

   Published: 12/10/2023
6. Navigating the Complexities of Next-Generation Endocrine Therapy in HR+ Breast Cancer

   Published: 28/09/2023
7. ASCO Breakthrough: Scientific Innovations and Emerging Technologies in Cancer Care

   Published: 17/08/2023
8. How Oncologists Are Confronting the Cancer Drug Shortage

   Published: 10/08/2023
9. AI Will Allow Doctors to Reclaim Time With Patients

   Published: 3/08/2023
10. Managing the Side Effects of Endocrine Therapy for Breast Cancer

    Published: 27/07/2023
11. The Emergence of Triplet Therapies in ccRCC in the Frontline Setting

    Published: 13/07/2023
12. Novel Therapies in GI Oncology at ASCO23

    Published: 28/06/2023
13. THOR, CONTACT-03, and Other Advances in GU Cancers at ASCO23

    Published: 27/06/2023
14. Spotlight on Immunotherapy at ASCO23

    Published: 26/06/2023
15. Highlights in Hematologic Malignancies at ASCO23

    Published: 23/06/2023
16. ADAURA, KEYNOTE-671, and Other Key Advances in Lung Cancer at ASCO23

    Published: 22/06/2023
17. SONIA, NATALEE, and Other Advances in Breast Cancer at ASCO23

    Published: 21/06/2023
18. Addressing the Impact of Prior Authorization on Access to Cancer Treatment

    Published: 8/06/2023
19. ASCO23: RELATIVITY-047, CheckMate-038, and Other Advances in Immunotherapy

    Published: 25/05/2023
20. ASCO23: COMMANDS, CAPTIVATE, and Key Studies in Hematologic Malignancies

    Published: 25/05/2023